HSBC Holdings’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Buy
66,034
+7,445
+13% +$244K ﹤0.01% 1560
2025
Q4
$2.19M Buy
58,589
+21,919
+60% +$721K ﹤0.01% 1530
2025
Q3
$1.01M Buy
36,670
+10,878
+42% +$375K ﹤0.01% 1789
2025
Q2
$815K Buy
25,792
+3,989
+18% +$128K ﹤0.01% 1899
2025
Q1
$714K Buy
21,803
+1,402
+7% +$50.3K ﹤0.01% 1910
2024
Q4
$701K Buy
20,401
+2,424
+13% +$83.3K ﹤0.01% 1982
2024
Q3
$715K Sell
17,977
-5,823
-24% -$205K ﹤0.01% 1843
2024
Q2
$731K Buy
23,800
+16,076
+208% +$483K ﹤0.01% 1807
2024
Q1
$259K Buy
+7,724
New +$248K ﹤0.01% 2534
2023
Q4
Sell
-10,026
Closed -$331K 2807
2023
Q3
$331K Buy
+10,026
New +$348K ﹤0.01% 2173
2023
Q1
Sell
-9,783
Closed -$530K 2830
2022
Q4
$530K Buy
9,783
+4,227
+76% +$232K ﹤0.01% 2263
2022
Q3
$247K Buy
+5,556
New +$271K ﹤0.01% 2519
2022
Q2
Sell
-7,290
Closed -$363K 3330
2022
Q1
$363K Buy
+7,290
New +$297K ﹤0.01% 2634

Other funds holding HRMY